Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: CHM hereby grants, sets-over, assigns, transfers and conveys unto TPL

CHM hereby grants, sets-over, assigns, transfers and conveys unto TPL

posted on Apr 06, 2009 11:39AM

Grant of Assignment

  1. CHM hereby grants, sets-over, assigns, transfers and conveys unto TPL:
    1. The exclusive, worldwide right to:
      1. regulate and control by license, sublicense, affiliation or other agreement the practice and/or use of the Licensed Technology
      2. otherwise pursue the commercialization thereof and the manufacture, sale and use of products and/or services relying on the Licensed Technology
      3. sue and collect for its own use and benefit all claims for damages by reason of past infringement or use of the Licensed Technology and
      4. pursue all remedies of whatsoever kind or nature for its own use and benefit relating to the past, present or future use of the Licensed Technology
    all pursuant to the terms of the ComAg entered into by the Parties contemporaneously herewith and
    1. That portion of the right, title and interest in and to the Licensed Technology which quantitatively corresponds to the Percentage Interest and entitlements of TPL undere the said ComAg and/or
    2. All of CHM's right, title and interest in and to the Licensed Technology which exists or may arise at the time of any termination of the said AomAg or Exhibit A thereof which is not based upon an adjudication of a default and a lawful termination by CHM under Section 10 of the said ComAg
  2. With respect to any rights to the Licensed Technology acquired by TPL under Section 2.1.3 above, CHM shall be entitled to receive that ceretain portion of the Net Recovery realized from the commercialization thereof which would have been otherwise payable to CHM under the terms of the said ComAg

http://www.colorforth.com/exhibitb.htm





Be well

Share
New Message
Please login to post a reply